Investment Analysts’ updated eps estimates for Monday, August 3rd:
Alumis (NASDAQ:ALMS) had its neutral rating reaffirmed by analysts at HC Wainwright. They currently have a $25.00 target price on the stock.
Autolus Therapeutics (NASDAQ:AUTL) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $10.00 target price on the stock.
BioAge Labs (NASDAQ:BIOA) had its buy rating reissued by analysts at BTIG Research. They currently have a $40.00 target price on the stock.
BrightSpring Health Services (NASDAQ:BTSG) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $90.00 price target on the stock.
ConvaTec Group (LON:CTEC) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a GBX 315 price target on the stock.
Precision BioSciences (NASDAQ:DTIL) had its buy rating reissued by analysts at HC Wainwright.
Evommune (NYSE:EVMN) had its neutral rating reissued by analysts at HC Wainwright.
First Business Financial Services (NASDAQ:FBIZ) had its outperform rating reissued by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $74.00 target price on the stock, up from their previous target price of $68.00.
FDM Group (LON:FDM) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.
Hilton Food Group (LON:HFG) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 815 price target on the stock.
Hawkins (NASDAQ:HWKN) had its buy rating reiterated by analysts at BWS Financial. The firm currently has a $200.00 price target on the stock.
International Consolidated Airlines Group (LON:IAG) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 645 target price on the stock.
Invinity Energy Systems (LON:IES) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 60 target price on the stock.
Illumina (NASDAQ:ILMN) had its overweight rating reissued by analysts at Piper Sandler. The firm currently has a $225.00 target price on the stock, up from their previous target price of $200.00.
Inovio Pharmaceuticals (NASDAQ:INO) had its overweight rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $4.00 target price on the stock.
ITV (LON:ITV) had its hold rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 85 price target on the stock.
JD Sports Fashion (LON:JD) had its sector perform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a GBX 100 target price on the stock.
Quaker Houghton (NYSE:KWR) had its buy rating reissued by analysts at Truist Financial Corporation. The firm currently has a $190.00 target price on the stock, up from their previous target price of $172.00.
Laureate Education (NASDAQ:LAUR) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. They currently have a $41.00 price target on the stock.
LB Pharmaceuticals (NASDAQ:LBRX) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $45.00 target price on the stock.
Ligand Pharmaceuticals (NASDAQ:LGND) had its outperform rating reiterated by analysts at Oppenheimer Holdings, Inc.. The firm currently has a $326.00 target price on the stock, up from their previous target price of $285.00.
Microchip Technology (NASDAQ:MCHP) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $125.00 price target on the stock.
McGraw Hill (NYSE:MH) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $19.00 price target on the stock.
MKS (NASDAQ:MKSI) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $600.00 price target on the stock.
MasTec (NYSE:MTZ) had its buy rating reiterated by analysts at Truist Financial Corporation. The firm currently has a $428.00 target price on the stock, down from their previous target price of $550.00.
NBT Bancorp (NASDAQ:NBTB) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. The firm currently has a $54.00 target price on the stock, up from their previous target price of $52.00.
NMI (NASDAQ:NMIH) had its market perform rating reiterated by analysts at Keefe, Bruyette & Woods. The firm currently has a $47.00 target price on the stock.
NatWest Group (LON:NWG) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 840 price target on the stock.
NatWest Group (LON:NWG) had its sector perform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a GBX 725 target price on the stock.
Omnicell (NASDAQ:OMCL) had its overweight rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $45.00 target price on the stock, down from their previous target price of $55.00.
Oruka Therapeutics (NASDAQ:ORKA) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $120.00 target price on the stock.
Provident Financial Services (NYSE:PFS) had its outperform rating reaffirmed by analysts at Keefe, Bruyette & Woods. The firm currently has a $28.00 price target on the stock, up from their previous price target of $26.00.
Peapack-Gladstone Financial (NASDAQ:PGC) had its outperform rating reiterated by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $56.00 target price on the stock, up from their previous target price of $55.00.
Precigen (NASDAQ:PGEN) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $14.00 target price on the stock.
Koninklijke Philips (NYSE:PHG) had its neutral rating reissued by analysts at UBS Group AG.
Perella Weinberg Partners (NASDAQ:PWP) had its outperform rating reissued by analysts at Keefe, Bruyette & Woods. They currently have a $21.00 target price on the stock, up from their previous target price of $19.00.
Quanta Services (NYSE:PWR) had its buy rating reiterated by analysts at Truist Financial Corporation. Truist Financial Corporation currently has a $976.00 target price on the stock, up from their previous target price of $940.00.
Rightmove (LON:RMV) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 665 price target on the stock.
Rightmove (LON:RMV) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 575 target price on the stock.
RWS (LON:RWS) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 170 price target on the stock.
Microlise Group (LON:SAAS) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 166 price target on the stock.
J Sainsbury (LON:SBRY) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 360 target price on the stock.
Shell (LON:SHEL) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 4,000 price target on the stock.
SpaceX (NASDAQ:SPCX) had its outperform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $225.00 target price on the stock.
Sphere Entertainment (NYSE:SPHR) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $190.00 price target on the stock.
SPX Technologies (NYSE:SPXC) had its buy rating reaffirmed by analysts at Truist Financial Corporation. Truist Financial Corporation currently has a $301.00 price target on the stock, up from their previous price target of $295.00.
Severn Trent (LON:SVT) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 3,220 target price on the stock.
Bancorp (NASDAQ:TBBK) had its outperform rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $79.00 price target on the stock, up from their previous price target of $77.00.
TriMas (NASDAQ:TRS) had its buy rating reaffirmed by analysts at BWS Financial. The firm currently has a $45.00 price target on the stock.
WSFS Financial (NASDAQ:WSFS) had its neutral rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $90.00 price target on the stock, up from their previous price target of $80.00.
Willis Towers Watson Public (NASDAQ:WTW) had its neutral rating reissued by analysts at Citigroup Inc.. They currently have a $345.00 target price on the stock, up from their previous target price of $300.00.
Winvia Entertainment (LON:WVIA) had its house stock rating reissued by analysts at Shore Capital Group Ltd.
Weyerhaeuser (NYSE:WY) had its hold rating reiterated by analysts at Truist Financial Corporation. They currently have a $28.00 price target on the stock, up from their previous price target of $27.00.
XPS Pensions Group (LON:XPS) had its buy rating reaffirmed by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 440 price target on the stock.
Receive News & Ratings for Alumis Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alumis Inc and related companies with MarketBeat.com's FREE daily email newsletter.
